RxDoctor Payments Data

Tom Kim, MD

Hospitalist · Kenosha, WINPI 1457465676

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Pfizer at 42.6% of the total. Reporting peaked in 2019 at $596 and has fallen 99.1% since, to $5 in 2025. Among hospitalist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,491in general payments, 2019–2025

Across 87 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$635
  • E.r. Squibb & Sons, L.L.C.$464
  • Medtronic$169
  • Shockwave Medical, Inc$114
  • Novo Nordisk$40
  • Jazz Pharmaceuticals Inc.$24
  • plus $46 from 4 others

What the payments were for

  • Food & beverage$1,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,491 in reported general payments places this provider in the 95th percentile of 679 hospitalist providers in Wisconsin.

See all hospitalist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$88,716
Medicare patients
287
Services billed
731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$11,308
Albuterol Sulfate HfaAlbuterol Sulfate12$560
Pantoprazole Sodium29$386
Valsartan15$251
Metoprolol Succinate25$245
Nifedipine ErNifedipine11$207
Cefdinir20$198
Atorvastatin Calcium29$165
Losartan Potassium13$78
Prednisone42$74
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$70
Carvedilol16$63
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$59
Metoprolol Tartrate11$56
Furosemide21$44

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$635$11,30820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 hospitalist providers in Wisconsin.

Other hospitalist in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →